Craft

Annexon Biosciences

Stock Price

$4.8

2024-05-01

Market Capitalization

$432.9 M

2024-05-01

Annexon Biosciences Summary

Company Summary

Overview
Annexon Biosciences is a biotechnology company that develops and provides therapeutics for disorders of the body, brain, and eye. It offers C1q, is initiating molecule of the classical complement pathway that activates an inflammatory cascade.
Type
Public
Status
Active
Founded
2007
HQ
Brisbane, CA, US | view all locations
Website
https://annexonbio.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Douglas Love

    Douglas Love, President, Chief Executive Officer, Director

  • Ted Yednock

    Ted Yednock, Executive Vice President, Chief Innovation Officer

  • Larry C. Mattheakis

    Larry C. Mattheakis, Executive Vice President. Chief Scientific Officer

  • Jennifer Lew

    Jennifer Lew, Executive Vice President, Chief Financial Officer

LocationsView all

1 location detected

  • Brisbane, CA HQ

    United States

    1400 Sierra Point Pkwy c 2nd

Annexon Biosciences Financials

Summary Financials

Net income (FY, 2023)
($134.2M)
Cash (FY, 2023)
$225.1M
EBIT (FY, 2023)
($143.7M)
Enterprise value
$239.1M

Footer menu